OCTOBER 8-10, 2019 | NATIONAL HARBOR, MD
DELIVERING INNOVATION ACCELERATING COMMERCIALIZATION
Join leadership from America’s seed fund, representing over $3.5B of early-state, high-risk technology funding for small business.
A University of Maryland (UMD) team has been awarded a $1 million grant by the National Science Foundation’s Integrative Strategies for Understanding Neural and Cognitive Systems (NCS) program to investigate the complex effects of intestinal serotonin on both gut and brain health. The project, “Developing engineering solutions to investigate microbiome-to-neuron communication,” aims to provide a more realistic picture of the complex gut-microbiome-brain axis system (GMBA).
These are the Baltimore Business Journal’s 2019 40 Under 40 honorees
This group of young professionals was chosen from a pool of nearly 500 nominations.
The move comes as Sands continues to expand its investing approach.
Baltimore-based Gemstone Therapeutics has received $250,000 in a new investment from the Maryland Momentum Fund.
The investment from the fund, which was created by the University System of Maryland to support startups created by students, faculty, alums and other affiliates, is part of a new funding round for Gemstone, according to the fund.
Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director: Masayuki Kobayashi) announced on August 29 that the company has entered into an agreement to invest up to US$30 million in Remiges Biopharma Fund II, LP a biopharma venture capital fund formed by Remiges Ventures, Inc. Taiho Pharmaceutical invested the same amount in the Remiges BioPharma Fund I established in 2014.
As students are returning for the semester at Johns Hopkins University, a new accelerator is launching for those who are forming new ventures.
Liftstream, a U.K.-based executive recruiting firm, released an oft referenced report called “A Public Reality for Women in Biotech Boardrooms” in 2016. Lifstream’s research found that only 7 to 9 percent of biotech CEOs were women, less than 11 percent of board seats were held by females and 98 percent of board chair positions were held by men. The report surveyed 177 publicly-listed biotechs that went through the IPO process from 2012 to 2015.
The rare autoimmune disease compromises the central nervous system.
For the third consecutive year, Children’s National Health System is co-locating its annual Symposium with The MedTech Conference, powered by AdvaMed. If you are interested in advancing innovation in pediatrics and exploring solutions to the challenges associated with device trials, we hope that you will join key industry stakeholders at the 7th Annual Pediatric Device Innovation Symposium on Sept. 22 in Boston, one day before The MedTech Conference.